Search research articles
Contact Us
Filters
Showing results (41-50 of 364) with videos related to
Page
of 37
Sort By:
The American Journal of Gastroenterology
|
January 17, 2025
Higher Relapse Rate in HBeAg-Negative Patients After Cessation of Tenofovir Alafenamide Compared With Entecavir or Tenofovir Disoproxil Fumarate
Hsin-Wei Fang, Wen-Juei Jeng, Tsung-Hui Hu, et al.
BMC Cancer
|
December 4, 2019
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
Ming-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, et al.
The Kaohsiung Journal of Medical Sciences
|
August 21, 2019
Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent
Jing-Houng Wang, Tsung-Hui Hu, Chien-Hung Chen, et al.
Cancers
|
October 27, 2022
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy
Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, et al.
Digestive Diseases and Sciences
|
August 17, 2022
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation
Shao-Ming Chiu, Kuo-Chin Chang, Tsung-Hui Hu, et al.
BMJ Supportive & Palliative Care
|
January 2, 2023
Quality of dying and death in intensive care units: family satisfaction
Fur-Hsing Wen, Ming Chu Chiang, Chung-Chi Huang, et al.
Hepato-Gastroenterology
|
March 15, 2012
Recurrent gastric varices bleeding after living-related liver transplantation successfully eradicated by splenic artery embolization
Lung-Sheng Lu, Fu-Chih Hung, Seng-Kee Chuah, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 20, 2017
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy
Kuo-Chin Chang, Yi-Hao Ye, Cheng-Kun Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
March 19, 2009
Clinical implications of alpha-fetoprotein in chronic hepatitis C
Wei-Chen Tai, Tsung-Hui Hu, Jing-Houng Wang, et al.
Plos One
|
November 3, 2016
Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, et al.
Page
of 37
Search research articles
Search
Showing results (41-50 of 364) with videos related to
Sort By:
Page
of 37
The American Journal of Gastroenterology
|
January 17, 2025
Higher Relapse Rate in HBeAg-Negative Patients After Cessation of Tenofovir Alafenamide Compared With Entecavir or Tenofovir Disoproxil Fumarate
Hsin-Wei Fang, Wen-Juei Jeng, Tsung-Hui Hu, et al.
BMC Cancer
|
December 4, 2019
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
Ming-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, et al.
The Kaohsiung Journal of Medical Sciences
|
August 21, 2019
Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent
Jing-Houng Wang, Tsung-Hui Hu, Chien-Hung Chen, et al.
Cancers
|
October 27, 2022
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy
Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, et al.
Digestive Diseases and Sciences
|
August 17, 2022
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation
Shao-Ming Chiu, Kuo-Chin Chang, Tsung-Hui Hu, et al.
BMJ Supportive & Palliative Care
|
January 2, 2023
Quality of dying and death in intensive care units: family satisfaction
Fur-Hsing Wen, Ming Chu Chiang, Chung-Chi Huang, et al.
Hepato-Gastroenterology
|
March 15, 2012
Recurrent gastric varices bleeding after living-related liver transplantation successfully eradicated by splenic artery embolization
Lung-Sheng Lu, Fu-Chih Hung, Seng-Kee Chuah, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 20, 2017
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy
Kuo-Chin Chang, Yi-Hao Ye, Cheng-Kun Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
March 19, 2009
Clinical implications of alpha-fetoprotein in chronic hepatitis C
Wei-Chen Tai, Tsung-Hui Hu, Jing-Houng Wang, et al.
Plos One
|
November 3, 2016
Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, et al.
Page
of 37